Tag: Vaccines

Vaccine effectiveness 54 percent against medically attended outpatient acute respiratory infection associated with influenza A in patients younger than 65 years

Parents report a mix of factors, including scientific evidence and political and social pressures, influencing their decision

High vaccine efficacy seen against RSV A and B subtypes, across age groups among those aged 60 years and older, and for those with coexisting conditions

Vaccination results in lower RSV-mediated lower respiratory tract disease meeting one of three definitions

The U.S. public health emergency declaration is scheduled to end in May

Changes include new section relating to COVID-19 vaccines, addition of newly licensed vaccine for hepatitis B

Vaccines have been licensed in past outbreaks and poultry are already vaccinated for diseases like infectious bronchitis

Highly effective against delta, moderately effective against omicron infection and hospital admission in infants

Changes to 2023 schedule include addition of new row for COVID-19, recommending vaccination for those aged 6 months to 18 years

Incidence of pertussis decreased among infants younger than 2 months after maternal Tdap vaccination implementation